Long-term application of NIV in COPD: pros and cons

Peter J. Wijkstra (Groningen, Netherlands)

Source: ERS Course 2018 - Noninvasive ventilation: advanced
Number: 7
Disease area: Airway diseases, Respiratory critical care

Slide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Peter J. Wijkstra (Groningen, Netherlands). Long-term application of NIV in COPD: pros and cons. ERS Course 2018 - Noninvasive ventilation: advanced

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung transplantation: the pros and cons
Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Year: 2016



Lung transplantation: the pros and cons
Source: International Congress 2015 – PG17 Lung fibrosis and sarcoidosis
Year: 2015




Portable versus laboratory-based sleep monitoring: pros and cons
Source: Annual Congress 2008 - Portable monitoring for sleep apnoea: the way forward?
Year: 2008


Field exercise testing: pros and cons
Source: Annual Congress 2007 - Field exercise testing: pros and cons
Year: 2007

Screening strategies pros and cons
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004


Allergy diagnosis: pros and cons of different tests, indications and limitations
Source: ISSN=ISSN 1810-6838, ISBN=, page=345
Year: 2007

Allergy diagnosis: pros and cons of different tests, indications and limitations
Source: Annual Congress 2006 - PG7 - Paediatric respiratory medicine: allergy for paediatric pulmonologists
Year: 2006



Evolving use of long-term NIV in COPD: Are we getting it right
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


Newborn screening for cystic fibrosis: pros and cons
Source: Breathe 2011; 8: 24-30
Year: 2011

Prescription opioid use in advanced COPD: benefits, perils and controversies
Source: Eur Respir J, 49 (6) 1700479; 10.1183/13993003.00479-2017
Year: 2017



Prescription opioid use in advanced COPD: benefits, perils and controversies
Source: Eur Respir J, 49 (6) 1700690; 10.1183/13993003.00690-2017
Year: 2017



Recruiting to telehealth has a role during discharge planning in COPD: A feasibility and acceptability study
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013


Clinical effectiveness of triple therapy in the management of COPD: A systematic review
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



Mechanical ventilation vs CPAP – what are the pro and cons?
Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)
Year: 2009

Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007


The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD
Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD
Year: 2011